Inventor
HARRIS PHILIP ANTHONY
US27 patents
⚠️ This page may combine multiple inventors who share the name “HARRIS PHILIP ANTHONY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SMITHKLINE BEECHAM CORP
14 patentsUS6369086B1Apr 9, 2002
Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors
SMITHKLINE BEECHAM CORP213 citations98
US7105529B2Sep 12, 2006
Substituted oxindole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors and compositions and methods of treating chemotherapy and radiation therapy side effects
SMITHKLINE BEECHAM CORP64 citations97
US7105530B2Sep 12, 2006
Pyrimidineamines as angiogenesis modulators
SMITHKLINE BEECHAM CORP72 citations96
US6815439B2Nov 9, 2004
Substituted aza-oxindole derivatives
SMITHKLINE BEECHAM CORP53 citations96
US6541503B2Apr 1, 2003
Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors
SMITHKLINE BEECHAM CORP22 citations92
US7262203B2Aug 28, 2007
Pyrimidineamines as angiogenesis modulators
SMITHKLINE BEECHAM CORP32 citations90
US6624171B1Sep 23, 2003
Substituted aza-oxindole derivatives
SMITHKLINE BEECHAM CORP13 citations84
US7238813B2Jul 3, 2007
Chemical compounds
SMITHKLINE BEECHAM CORP20 citations81
US7189712B2Mar 13, 2007
1,3-Oxazole compounds for the treatment of cancer
SMITHKLINE BEECHAM CORP13 citations81
US7109209B2Sep 19, 2006
Pyrazolopyridines, process for their preparation and use as therapeutic compounds
SMITHKLINE BEECHAM CORP8 citations72
US7034030B2Apr 25, 2006
Pyralopyridines, process for their preparation and use as therapeutic compounds
SMITHKLINE BEECHAM CORP6 citations72
US6964977B2Nov 15, 2005
Oxindole derivatives
SMITHKLINE BEECHAM CORP10 citations68
US7279473B2Oct 9, 2007
Pyrazolopyridazine derivatives
SMITHKLINE BEECHAM CORP5 citations58
US7163940B2Jan 16, 2007
Pyrazolopyridinyl pyrimidine therapeutic compounds
SMITHKLINE BEECHAM CORP1 citations47
GLAXOSMITHKLINE IP DEV LTD
7 patentsUS9556152B2Jan 31, 2017
Heterocyclic amides as kinase inhibitors
GLAXOSMITHKLINE IP DEV LTD29 citations96
US10292987B2May 21, 2019
Heterocyclic amides as kinase inhibitors
GLAXOSMITHKLINE IP DEV LTD4 citations81
US10940154B2Mar 9, 2021
Heterocyclic amides as kinase inhibitors
GLAXOSMITHKLINE IP DEV LTD3 citations70
US10933070B2Mar 2, 2021
Heterocyclic amides as kinase inhibitors
GLAXOSMITHKLINE IP DEV LTD2 citations70
US10899716B2Jan 26, 2021
Heterocyclic amides as kinase inhibitors
GLAXOSMITHKLINE IP DEV LTD2 citations69
US10590085B2Mar 17, 2020
Heterocyclic amides as kinase inhibitors
GLAXOSMITHKLINE IP DEV LTD3 citations69
US11485710B2Nov 1, 2022
Heterocyclic amides as kinase inhibitors
GLAXOSMITHKLINE IP DEV LTD0 citations59
GLAXO WELLCOME INC
2 patentsUS6268391B1Jul 31, 2001
Benzylidene-1,3-dihydro-indol-2-one derivatives a receptor tyrosine kinase inhibitors, particularly of Raf kinases
GLAXO WELLCOME INC238 citations96
US6387919B1May 14, 2002
Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors
GLAXO WELLCOME INC34 citations90